Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.

Kueffer PJ, Maitz CA, Khan AA, Schuster SA, Shlyakhtina NI, Jalisatgi SS, Brockman JD, Nigg DW, Hawthorne MF.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6512-7. doi: 10.1073/pnas.1303437110. Epub 2013 Mar 27.

2.

Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model.

Heber EM, Hawthorne MF, Kueffer PJ, Garabalino MA, Thorp SI, Pozzi EC, Monti Hughes A, Maitz CA, Jalisatgi SS, Nigg DW, Curotto P, Trivillin VA, Schwint AE.

Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16077-81. doi: 10.1073/pnas.1410865111. Epub 2014 Oct 27.

3.

Na3[B20H17NH3]: synthesis and liposomal delivery to murine tumors.

Feakes DA, Shelly K, Knobler CB, Hawthorne MF.

Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3029-33.

4.

Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes.

Feakes DA, Shelly K, Hawthorne MF.

Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1367-70.

5.

Liposomes as drug delivery vehicles for boron agents.

Hawthorne MF, Shelly K.

J Neurooncol. 1997 May;33(1-2):53-8.

PMID:
9151223
6.

Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes.

Shelly K, Feakes DA, Hawthorne MF, Schmidt PG, Krisch TA, Bauer WF.

Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9039-43.

7.

Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).

Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H.

J Control Release. 2004 Aug 11;98(2):195-207.

PMID:
15262412
8.

Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.

Heber EM, Kueffer PJ, Lee MW Jr, Hawthorne MF, Garabalino MA, Molinari AJ, Nigg DW, Bauer W, Hughes AM, Pozzi EC, Trivillin VA, Schwint AE.

Radiat Environ Biophys. 2012 May;51(2):195-204. doi: 10.1007/s00411-011-0399-0. Epub 2012 Jan 21.

PMID:
22271404
9.

Synthesis and in vivo murine evaluation of Na4[1-(1'-B10H9)-6-SHB10H8] as a potential agent for boron neutron capture therapy.

Feakes DA, Waller RC, Hathaway DK, Morton VS.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6406-10.

10.

Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):663-72.

PMID:
9112465
11.
12.

Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):209-18.

PMID:
10758326
13.

New drugs for BNCT: an experimental approach.

Weissfloch L, Bremer M, Lemmen P, Probst T, Wagner M, Peller M, Auberger T, Senekowitsch-Schmidtke R, Tempel K, Molls M.

Strahlenther Onkol. 1999 Jun;175 Suppl 2:118-20.

PMID:
10394418
14.

Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.

Kreimann EL, Miura M, Itoiz ME, Heber E, Garavaglia RN, Batistoni D, Rebagliati RJ, Roberti MJ, Micca PL, Coderre JA, Schwint AE.

Arch Oral Biol. 2003 Mar;48(3):223-32.

PMID:
12648560
15.

Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.

Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):267-77.

PMID:
14697448
16.

Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.

Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):920-7.

PMID:
15465210
17.

Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.

Miyajima Y, Nakamura H, Kuwata Y, Lee JD, Masunaga S, Ono K, Maruyama K.

Bioconjug Chem. 2006 Sep-Oct;17(5):1314-20.

PMID:
16984142
18.

Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH.

J Neurooncol. 1997 May;33(1-2):59-70.

PMID:
9151224
19.

[Minimally invasive cytoselective radiation therapy using boron neutron capture reaction].

Nakamura H.

Yakugaku Zasshi. 2010 Dec;130(12):1687-94. Review. Japanese.

20.

Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.

Molinari AJ, Pozzi EC, Monti Hughes A, Heber EM, Garabalino MA, Thorp SI, Miller M, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE.

Radiat Res. 2012 Jan;177(1):59-68. Epub 2011 Oct 10.

PMID:
21980958
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk